Document is current
Any future updates will be listed below
-
Authors
Cheema, Baljash https://orcid.org/0000-0002-4105-0579
Tibrewala, Anjan
- License Information
-
More Information
Article History
Accepted: 15 April 2025
First Online: 23 April 2025
Declarations
:
: Dr. Cheema has received consulting fees from Caption Health, Inc. and Viz.ai, served on an advisory board for Novo Nordisk, is an advisor with equity interest in Healthspan, Inc. and Zoe Biosciences, has received speaking fees and honoraria for Bristol Meyers Squibb, and was a Sub-Investigator for the SEISMIC-HF 1 study. Dr. Tibrewala has received consulting fees from Boehringer Ingelheim, research funding from Omron Healthcare, and was the site Principle Investigator for the SEIMIC-HF 1 study.
